公司資料
Catheter Precision 股價、新聞與催化劑
- 股票代碼:
- VTAK
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
0.23 USD (-18.57%)
收盤價
最後更新: 2026年8月17日
2.58M USD
市值
股價為何變動
The latest monitored company update is “Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market.” The corresponding closing-price reaction is not yet available.
公司概覽
業務概覽
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
所在地與產業分類
Catheter Precision is headquartered in the United States and listed on NASDAQ. It sits in cardiac-device medtech rather than biotechnology.
商業模式特徵
The company depends on device adoption, physician training, and regulatory or commercial milestones in electrophysiology labs. Investors watch product uptake, procedure placement, and operating execution.
生技產業定位
Catheter Precision occupies a cardiac-device niche within healthcare innovation. It is not biotech, but it belongs in the procedural-medtech layer where clinical adoption drives value.
未來催化劑
- Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path. The market will care about whether the platform can keep winning procedure share.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。